Klas Holmlund headshot

Klas Holmlund

Chief Financial Officer

Klas Holmlund, CFA, MBA, is the Chief Financial Officer of Lyndra Therapeutics and is responsible for financial operations and investor relations at the company. He is an experienced corporate finance biopharma executive with demonstrated abilities in building an outstanding global corporate finance organization from the ground up and developing diverse top performing teams. He has a proven track record of negotiating and executing strategic multi-billion capital raises, directly funding and enabling future company growth.

Prior to Lyndra, Mr. Holmlund led the corporate treasury at Vertex Pharmaceuticals where his responsibilities included international corporate governance, global liquidity management, investments, capital markets, financial risk management, banking and financial operations. His professional background also includes various corporate finance and investment roles at General Motors and Evergreen Investments.

Mr. Holmlund has a Master of Business Administration from Yale University, a Master of Science in finance from Boston College and a Bachelor of Arts in economics from Lewis & Clark College. He has previously served on the Board of the New England Association for Finance Professionals and is a CFA charterholder. He is an avid skier who enjoys dabbling in the kitchen when time permits.

Member Highlight